Psychedelics Show Promise For Treating Postpartum Depression
Reunion Neuroscience is conducting clinical trials on an injectable, single-dose drug that produces a state that’s similar to psilocybin but is generally much shorter, lasting about four hours. It also requires significantly less time in a clinical setting than medications already on the market.